chrisvoncsefalvay/vaers-outcomes huggingface dataset:
back muscle aches 2 days later (10 days ago); muscle aches 2 days later (10 days ago); This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back muscle aches 2 days later (10 days ago)) and MYALGIA (muscle aches 2 days later (10 days ago)) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced BACK PAIN (back muscle aches 2 days later (10 days ago)). 09-Mar-2021, the patient experienced MYALGIA (muscle aches 2 days later (10 days ago)). At the time of the report, BACK PAIN (back muscle aches 2 days later (10 days ago)) and MYALGIA (muscle aches 2 days later (10 days ago)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. Patient was taking Tylenol and Advil occasionally to treat symptoms.   This case was linked to US-MODERNATX, INC.-MOD-2021-051435 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-051435:Crosslinked with dose 1
This spontaneous report was received from a consumer referring to an 85 year old female patient (reporter's mother). The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date in approximately June 2016 (reported as 2 or 3 weeks ago), the patient was vaccinated with an expired dose of ZOSTAVAX, subcutaneously, 1 shot (dose, lot# and expiry date not reported) for prevention of shingles. Subsequently, after 4 or 5 days approximately in June 2016 (also reported as 2 or 3 weeks ago), the patient started to develop symptoms which was very swollen and felt warm at the injection site. The patient sought medical attention- physician office visit, who did not provide any treatment. No lab test was performed. At the time of this report, the patient was slowly recovering as the injection site reaction was beginning to dissipate. No further information provided. Additional information has been requested.
Diarrhea; Is not feeling well; This is a spontaneous report from a contactable consumer. A 87-years-old female patient (age at vaccination: 87years) received first dose BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration in right arm on 04Feb2021 as 1ST DOSE, SINGLE for covid-19 immunisation (at clinic) patient stated the appointment time of vaccination was 10:30. Medical history of the patient was allergic to molds and mucus and concomitant medications unspecified allergy spray indicated for stuffy mucus, allergy shots indicated for allergy to molds from unknown to ongoing. No relevant tests were performed to patient prior to vaccination. Patient didn't receive any other vaccinations with in 4weeks time of vaccination. The patient stated that she got the vaccine she did not report that she takes a shot for allergies. Since getting the vaccine she has not been feeling up to par. On 04Feb2021 She has also been having diarrhea. she stated that the diarrhoea was not watery. It was soft and not much is coming out, Patient is not feeling well. Events did not require a visit to emergency room or physician office. The outcome of the events Malaise was unknown and the outcome of diarrhoea was recovering.  Follow-up attempts are completed. No further information is expected.
I26.99 ACUTE PULMONARY EMBOLISM 10/6/2022 ACUTE RESPIRATORY FAILURE I95.9 HYPOTENSION 9/7/2022 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 10/6/2022 ACUTE RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/9/2022 ACUTE RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/8/2022 ACUTE RESPIRATORY FAILURE R09.02 HYPOXEMIA 8/8/2022 ACUTE RESPIRATORY FAILURE I26.99 ACUTE PULMONARY EMBOLISM 10/6/2022 CANCER METASTATIC TO BONE I95.9 HYPOTENSION 9/7/2022 CANCER METASTATIC TO BONE J96.00 ACUTE RESPIRATORY FAILURE 10/6/2022 CANCER METASTATIC TO BONE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/9/2022 CANCER METASTATIC TO BONE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/8/2022 CANCER METASTATIC TO BONE R09.02 HYPOXEMIA 8/8/2022 CANCER METASTATIC TO BONE I26.99 ACUTE PULMONARY EMBOLISM 10/6/2022 ACUTE RESPIRATORY FAILURE I95.9 HYPOTENSION 9/7/2022 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 10/6/2022 ACUTE RESPIRATORY FAILURE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/9/2022 ACUTE RESPIRATORY FAILURE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/8/2022 ACUTE RESPIRATORY FAILURE R09.02 HYPOXEMIA 8/8/2022 ACUTE RESPIRATORY FAILURE I26.99 ACUTE PULMONARY EMBOLISM 10/6/2022 CANCER METASTATIC TO BONE I95.9 HYPOTENSION 9/7/2022 CANCER METASTATIC TO BONE J96.00 ACUTE RESPIRATORY FAILURE 10/6/2022 CANCER METASTATIC TO BONE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/9/2022 CANCER METASTATIC TO BONE J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/8/2022 CANCER METASTATIC TO BONE R09.02 HYPOXEMIA 8/8/2022 CANCER METASTATIC TO BONE I26.99 ACUTE PULMONARY EMBOLISM 10/6/2022 HX OF BREAST CANCER IN SITU I95.9 HYPOTENSION 9/7/2022 HX OF BREAST CANCER IN SITU J96.00 ACUTE RESPIRATORY FAILURE 10/6/2022 HX OF BREAST CANCER IN SITU J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/9/2022 HX OF BREAST CANCER IN SITU J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 8/8/2022 HX OF BREAST CANCER IN SITU R09.02 HYPOXEMIA 8/8/2022 HX OF BREAST CANCER IN SITU
AFTER GIVING THE SHOT CUSTOMER REPORTED HAVING HIVES , GAVE  HER BENADRYL
The event was that on Nov 6 I tested positive for Covid and was sick for several days.  I had taken a PCR test prior on Nov 2 as part of a requirement for overseas travel.  When I began to feel ill on Nov 7 I confirmed positive Covid   Given that this was 4th of the shots and that I had covid in April of 2022 this lot has proven ineffective in preventing covid.
2FEB97 inc temp, cough, h/a;3FEB97 RVC obtained;7FEB97 cult positive influenza A;
Pneumonia; Emphysema; This initial spontaneous report was received from a lawyer on 30-APR-2020, regarding a case in litigation and refers to a male patient of unknown age. His medical history, concurrent conditions or concomitant medications were not reported. On or around 23-NOV-2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (the dosage regimen information was not reported) for routine health maintenance and its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as "shortly after receiving" zoster vaccine live (ZOSTAVAX)), the patient suffered chest pains and breathing problems resulting in a diagnosis of emphysema and pneumonia. It was mentioned that these injuries were caused by zoster vaccine live (ZOSTAVAX). As a direct and proximate result of vaccination, the patient's symptoms had resulted in physical limitations not present prior to vaccination, he experienced mental and emotional distress due to resulting physical limitations and seriousness of his conditions. The patient sustained severe and permanent personal injuries. Further, as a tragic consequence of vaccination, the patient suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental, anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. At the time of the report, the outcome of pneumonia and emphysema was not recovered. The reporter considered this case as serious due to disabling. Upon internal review, pneumonia was considered to be medically significant.
After the vaccine I did not feel well for about a day. On 12/02/2021, my right arm lymph nodes were very swollen. I contacted my doctor and was advised to monitor the swelling and to take an analgesic for the pain. I waited ten weeks before getting my mammogram and I had to have a biopsy of my lymph nodes. The results were within normal range.
Patient in clinic today with mother. Right upper deltoid area of arm red and swollen, warm to touch - area. Mother has not tried Tylenol or anything yet. Child is very active, not favoring that arm. Counseled via interpreter clinic aide to apply ice pack or cool cloth to affected area. Give Tylenol for age every 4 hours as needed per directions on medication. Mom took child and stated she planned to see PMD on 3/17/06. Unable to reach Mom by phone on 3/20/06 and 3/21/06.
I woke up that morning, I went to stand up and my leg gave out because my ankle was in a lot of pain. I had to call in to work. I called my doctor the next day and they told me to ice it, elevate it, and rest. The doctor thought it was a sprain. That day I went to work with a brace. It was hurting but then after about 4 days it went away. I still experience it very randomly first thing in the morning, is when it hurts. I am also having short term memory loss. I am not sure if it is related to the vaccine or not.
This spontaneous report as received from a health professional refers to a 2 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
15 month PE 8-2-04. 8-8-04 lethargic. Diagnosis encephalitis 8-11-04. CSF PCR + HSV - mid August 2004 10/18/07-records received for DOS-8/8-8/9/04-DC DX: Acute viral illness. Presented with fever and history of not acting right. Seen in clinic day before, lethargic, some vomiting and runny nose. DX: otitis media. Temp on admission 102.3. Admitted for observation. Per 60 day follow up: On set of illness around same time as vaccination. Patient has seizures and developemental delay. Dx with herpes encephelitis as likely cause of seizures & delay.
Horrible Headache Dizziness Chest Pains Shortness of Breath STILL ALMOST A WEEK LATER
pt c/o throat tightness & SOB tx @ ER;2 days later c/o chest pain;
Pt came in for H1N1, she was asked if she had any cold sxs; fever, she said no. Pt was given H1N1 nasal mist .012 cc. After pt received the mist she then asked if she should have gotten it - she is 11 weeks pregnant. I called CDC and then filed report with VAERS.
the first dose I received was Moderna and the second dose was Pfizer and no one ever told me; after both doses was tenderness at injection site.; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) and VACCINATION SITE PAIN (after both doses was tenderness at injection site.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EL9269) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) and VACCINATION SITE PAIN (after both doses was tenderness at injection site.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) had resolved and VACCINATION SITE PAIN (after both doses was tenderness at injection site.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Thyroid pills and Cholesterol pills.
vaccinated 1/13.  presented for COVID screening on 1/14 due to a + exposure.  Test was +.  Patient came to ED on 1/16 with weakness, congestion, poor appetite, coughing.  Previous headache and sweating had resolved by the time she presented.  Discharged with isolation instructions.  Returned to ED late on 1/22 with " right-sided chest pain described as sharp constant 6/10 nonradiating pain localized to the right side of upper chest, shortness of breath with exertion since this afternoon.  She does endorse subjective fevers, with associated increased coughing which is productive in nature, shortness of breath."  Admitted to ICU early 1/23, transferred to Medical Center on 2/4/21.
body ache; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache), CHILLS (chills) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN (body ache), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN (body ache), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported. No medical history was provided by the reporter.
I woke that Friday and the bottom half of my right eye was full of netting, within a week entire eye was like that, so about 50% of those optical nerves are permanently dead. Saw Dr. on 05/26/2021. Doctor said My blood supply to eye was restricted, right eye, to the point most of my optical nerves died. I also feel pressure in my head behind my eye. Turns out I also developed a sty. This head pressure on right side of head is killing me. My back and neck are also very sore.
Cold sores/blisters in roof of mouth cleared up; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Cold sores/blisters in roof of mouth cleared up) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03621A and 031B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Cold sores/blisters in roof of mouth cleared up). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Cold sores/blisters in roof of mouth cleared up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Chest pain and throat tightness started approximately 3 hours after vaccination. Chest pain with a sensation of numbness radiated into patient's shoulder blades and left arm. Patient also endorses pain in ankles and feeling as she has a fever, but no documented fever present. Patient has a history of viral pericarditis in 2018. Patient admitted to observation for monitoring and treated with ibuprofen and acetaminophen as needed. Patient discharged the following morning with instruction to continue ibuprofen and/or acetaminophen as needed for vaccine side effects.
No additional AE reported; Patient who was previously administered MMRII had missed MMRII Dose on 01/04/2023; This spontaneous report was received from a pharmacist referring to a patient of unknown gender and age. Information of the patient's pertinent medical history, concomitant therapy, concurrent condition and drug reactions/allergies was not reported.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection (dose, strength, frequency, lot #, expiration date and route of administration were not provided) for prophylaxis.  On 04-JAN-2023, the patient missed dose of mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (product dose omission issue). The reporter was unable to further clarify these statements at current call time. No additional adverse event (AE) reported (no adverse event). No PQC reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05May2022 as dose 4 (booster), single (Lot number: FM9492) at the age of 74 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "high BP" (unspecified if ongoing), notes: high BP; "Demylenating disease of CNS" (unspecified if ongoing), notes: Demylenating disease of CNS; "wheat" (unspecified if ongoing), notes: known allergies wheat. Concomitant medication(s) included: NIFEDIPINE, start date: 03Apr2021. Past drug history included: Dilaudid, reaction(s): "known allergy: dilaudid", notes: known allergies dilaudid. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment for COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received treatment with Paxlovid for the treatment of COVID-19. Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors, however a contributory role of the suspect drug BNT162B2 to the reported events drug ineffective and COVID-19 cannot be ruled out.
stabbing chest pains and had to be brought to the ER; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 15 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Dec2021 (Batch/Lot number: unknown) at the age of 15 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), administration date: 22Nov2021, when the patient was 15 years old, for COVID-19 immunization. The following information was reported: CHEST PAIN (hospitalization) with onset 16Dec2021 01:00, outcome "not recovered", described as "stabbing chest pains and had to be brought to the ER". The patient was hospitalized for chest pain (hospitalization duration: 3 day(s)). The event "stabbing chest pains and had to be brought to the er" was evaluated at the emergency room visit. It was unknown if therapeutic measures were taken as a result of chest pain. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
This medically confirmed spontaneous report (initial receipt: 06-Nov-2012) concerns a female patient. On an unknown date the patient received AFLURIA (batch number: P50508) injection at a pharmacy as 'shingles vaccine' (as reported). On 06-Nov-2012 the patient then had a scheduled doctor's appointment and was diagnosed with Lyme's disease at time of doctor's appointment.
Major diarrhea; This is a spontaneous report from a non contactable consumer, the patient. A 27-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) in the arm left on 03Apr2021, at 11:30, (at the age of 27-years-old) as a dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 the patient experienced major diarrhea. No therapeutic measures were taken as a result of reported event. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event major diarrhea was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
HAD A SEIZURE EARLY AM OF SATURDAY, 8-22 -2020 HAD A FEVER ON 8-21-2020 OF AT LEAST 105 R  BABY TURNED BLUE & STOPPED BREATHING SO MOM STARTED CPR  CALLED 911 & TAKEN BY AMBULANCE TO ER DIAGNOSIS IN ER- FEBRILE SEIZURE, DISCHARGED AND FOLLOW UP IN OFFICE 8/24/2020.
Hives began to develop on the patient's scalp and face beginning on 01/25/2018 and over the next two to three days had continued spreading to the torso, arms, and legs. The hives on the scalp developed into open oozing sores that would itch, sting, and produce momentary episodes of intense pain. Hives on the face, torso, legs, and arms would only occasionally itch. The patient did seek professional medical attention on 01/28/2018 at an immediate care facility. The doctor on duty performed a visual examination following a medical technician's initial report of vitals. Based on the doctor's diagnosis a perscription of Methylprednisolone 4mg dosepk and a recommendation to use over-the-counter Benadryl.
About 12 hours after my second shot, I developed a high fever of 102 degrees. I had a terrible headache, body aches, and nausea for about 14 hours.
supposed to have #2 around Apr 2020 but did not due to covid; This case was reported by a consumer via call center representative and described the occurrence of social problem in a 38-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on an unknown date in December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.  Additional details were provided as follows: The patient-self reported this case. The age at vaccination was not applicable for this report. The patient was about to receive the second dose around April 2020, but did not due to covid. The patient enquired if he/she could take the second dose and if it would be effective.